Redefining Every Stage of Investment (RESI) Seed to Exit

We are proud to be exhibiting at RESI London 2025, the premier partnering event connecting early-stage biotech and medtech innovators with investors and strategic partners. This conference brings together entrepreneurs, venture capital firms, licensing partners, and service providers who share a passion for advancing promising science into impactful therapies.

At Certara, we understand the unique challenges that biotech companies face in bringing new therapies from discovery through early clinical development. From designing efficient early development strategies to supporting investor due diligence, we provide the expertise and tools to help you de-risk programs, accelerate timelines, and maximize the value of your assets.

How Certara Supports Biotechs:

• Early Development Services: Optimize your nonclinical and early clinical strategy to increase confidence in your first-in-human studies. Learn more ›
• Bio Venture Catalyst: Translate scientific innovation into a viable development strategy that attracts investment and partnership. Learn more ›
• Due Diligence & Asset Evaluation: Support critical investment and partnering decisions with objective scientific and regulatory insights. Learn more ›

If you’re attending RESI London, visit our exhibit to meet Certara experts and discover how we can help you unlock the full potential of your science.